Bassan Abraham insider trades
Bassan Abraham has filed 10 Form 4s with the SEC that we hold, for CRGX (Director), LENZ Therapeutics, Inc. (GRPH) (Director), Rani Therapeutics Holdings, Inc. (RANI) (Director) and Septerna, Inc. (SEPN) (Director). None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2022-06-22 and the latest 2026-06-30.
CRGX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
LENZ Therapeutics, Inc. (GRPH)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Rani Therapeutics Holdings, Inc. (RANI)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Septerna, Inc. (SEPN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1864485) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms